Inhibition of MMP-9 is discussed as a therapeutic strategy for multiple sclerosis, since inhibition of MMP-9 by Interferon-β led to reduced transmigration and decreased permeability of the blood brain barrier in patients [43], [44], [45]. Here, MMP9 is linked to multiple sclerosis.